SEVERE APLASTIC ANEMIA
Clinical trials for SEVERE APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method aims to cut immune suppression in bone marrow failure patients
Disease control Recruiting nowThis study tests a special stem cell transplant that removes certain immune cells to lower the risk of graft-versus-host disease (GVHD) and reduce the need for long-term immune-suppressing drugs. It is for people with inherited bone marrow failure disorders like Fanconi anemia. T…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New hope for bone marrow failure: drug trial targets immune attacks
Disease control Recruiting nowThis study tests a drug called ruxolitinib in adults with immune bone marrow failure, where the immune system attacks the bone marrow. Participants take the drug twice daily for up to 6 months to see if it can control the disease and improve blood counts. The goal is to find a be…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
Could a simple pill combo transform severe anemia care?
Disease control Recruiting nowThis study tests whether starting two oral drugs (cyclosporine and eltrombopag) early, before the standard treatment, is safe and practical for people with severe aplastic anemia. Participants take the pills for 6 months and may later receive standard therapy. The goal is to see …
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 17, 2026 02:57 UTC
-
New hope for rare blood disorder: Half-Matched transplants show promise
Disease control Recruiting nowThis study tests a bone marrow transplant from a half-matched (haploidentical) donor for people with severe aplastic anemia, a rare condition where the bone marrow fails to make enough blood cells. The goal is to see if this approach can safely restore normal blood cell productio…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Safer stem cell transplants? new study aims to reduce Life-Threatening side effects
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with severe aplastic anemia and other bone marrow failure diseases. The goal is to lower the risk of serious complications, like graft-versus-host disease, by giving fewer donor white blood cells. Participants rece…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New cord blood transplant could help bone marrow disease patients
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with severe aplastic anemia or a related bone marrow disease called MDS. It combines stem cells from a family member with specially grown cord blood cells from an unrelated donor to help the new cells grow faster a…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Cord blood transplants expanded to thousands in new access study
Disease control Recruiting nowThis study gives people with blood cancers, immune disorders, and other serious diseases access to unlicensed cord blood units for transplant. It includes both children and adults of any age. The main goal is to see how well the body recovers its white blood cells after the trans…
Matched conditions: SEVERE APLASTIC ANEMIA
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New transplant trial offers hope for severe aplastic anemia patients
Disease control Recruiting nowThis study tests a bone marrow transplant for people newly diagnosed with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. The transplant uses marrow from a partially matched family member or unrelated donor. The goal is to improve surviv…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
20-Year study to track rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows 1,000 people aged 2 and older with bone marrow failure diseases (like severe aplastic anemia) for up to 20 years. Researchers want to understand how these diseases and their treatments affect the body over time. Participants have regular check-ups, blood tests,…
Matched conditions: SEVERE APLASTIC ANEMIA
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:58 UTC